War in Ukraine: without Russia, Crimea will become “one of the best places to live in Europe”, assures Zelensky
British justice: traditional wigs, deemed “discriminatory” by black lawyers, about to be abandoned
Israel: for the first time, Eden Golan sings in public the original version of her song rejected during Eurovision
“Teachers are there to teach facts to students”: in the United Kingdom, the government wants to backtrack on gender theory in schools
Cancer: Klineo, a platform allowing patients to access new therapies
Suicide attempts and self-harm on the rise among young girls
In Europe, 10,000 people die every day from cardiovascular disease
Brussels raises Spanish GDP forecasts to 2.1% and foresees a deficit of 3% in 2024
Another incident on a Boeing, this time on a Montreal-Lyon flight forced to turn around
Unemployment insurance reform could affect up to a third of beneficiaries, according to Unédic
CPF: it is now much more difficult to use your account to finance your motorcycle license
Audible signal, hardening of the accelerator… New cars must be equipped with an “intelligent” speed limiter
At the Art Rock festival, the audacious power of Zaho de Sagazan
Old Hollywood reels, a well-kept treasure in a shed
Rachida Dati announces a mandatory “children’s manager”, from this summer, on every shoot with minors
Three World War II bunkers found almost intact in Belgium
Omoda 7, another Chinese car that could be manufactured in Spain
BYD chooses CA Auto Bank as financial partner in Spain
Tesla and Baidu sign key agreement to boost development of autonomous driving
Skoda Kodiaq 2024: a 'beast' plug-in hybrid SUV
The home mortgage firm rises 3.8% in February and the average interest moderates to 3.33%
This is how housing prices have changed in Spain in the last decade
The home mortgage firm drops 10% in January and interest soars to 3.46%
The jewel of the Rocío de Nagüeles urbanization: a dream villa in Marbella
Europeans: a “Free Palestine” list, whose logo advocates the disappearance of Israel, officially a candidate
New Caledonia: Zemmour accuses Le Pen of “giving in to the thugs and looters”
Europeans: between the RN and the “euro-gagas”, the communist Léon Deffontaines dreams of breaking through to the left
Europeans: professor threatened with death Didier Lemaire shows his support for François-Xavier Bellamy
These French cities that will boycott the World Cup in Qatar
NBA: Dallas knocks out Oklahoma City and advances to the Western Conference final
Boxing: “In the end, all our opponents will be defeated”, Zelensky relished Usyk’s coronation
Vendée Globe: Crémer takes an option on qualification by finishing The Transat just in time
PSG: Luis Enrique does without Mbappé for the last Ligue 1 match in Metz
The Beyfortus treatment, which aims to immunize babies against the main virus causing bronchiolitis, will ultimately be reserved for maternity wards in its version intended for the smallest infants, the Ministry of Health announced on Tuesday September 26.
The ministry “is adapting its strategy in order to protect as a priority the children most at risk of being hospitalized,” he said in a press release, explaining its decision by the strong demand encountered by this treatment since the start of a vast immunization campaign in mid-September.
Beyfortus, developed by the Sanofi group, is a treatment which aims to prevent babies from being infected with the respiratory syncytial virus (RSV). The latter is the main cause of bronchiolitis. This, which results in breathing difficulties, is generally not serious but can become complicated and lead to hospitalization. Every year it causes an epidemic which, last season, was particularly intense.
In this context, the French government launched an immunization campaign for babies on September 15. However, this has encountered a “very high membership rate”, according to the Ministry of Health. At the National Assembly, the minister, Aurélien Rousseau, hailed an “exceptional success”.
But this strong demand forces the ministry to review the organization of the campaign “for the sake of good management of available stocks”. Until then, all parents could order treatment in pharmacies if their baby had been born since February.
From now on, the 50 mg version of the treatment, intended for babies weighing less than five kilograms, will be reserved for maternity wards. Pharmacies will be able to continue to order the 100 mg version, which is intended for babies of greater weight.
This decision is justified by the fact that “infants under one month old are most at risk of developing a serious form of bronchiolitis,” explains the ministry, without mentioning the case of babies in this age group but already discharged. maternity. According to the latest data, dating from last week, hospitalizations linked to bronchiolitis are starting to increase but remain at a “low” level.
